• Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies such as the Food and Drug Administration (FDA) must obtain approval from the Office of Management and Budget Review (OMB)


Continue Reading FDA Asks OMB to Approve Certain Information Collection Techniques to Support Further Research into Consumer Behavior Regarding Food and Other Areas

 9th Circ. Judge Doubts General Mills False Label Claims (subscription to Law360 required)

  • Proposed class action lawsuits against Kellogg, Post, and General Mills, with a common lead plaintiff in the


Continue Reading 9th Circuit Judge Asks What Amount of Added Sugar in a Product Makes the Product Unhealthy, a Question About Which Other Courts Have Ruled There is a Material Issue of Fact in Allowing Similar Cases to Proceed

  • A group of seven CBD brands (Boulder Botanicals & Bioscience Labs, CBDistillery, CBD American Shaman, Charlotte’s Web Holdings, Columbia Care, HempFusion, and Kannaway) have committed to collectively sponsor ValidCare (a


Continue Reading CBD Brands Commit to Sponsor Observational Research to Evaluate the Impact of Daily CBD Use on the Liver Function of Healthy Adults

  • In late May 2020, the North American Olive Oil Association submitted a citizen petition to FDA, asking the Agency to adopt science-based, enforceable standards for olive oil. In its petition


Continue Reading North American Olive Oil Association Submits Citizen Petition to FDA Asking for Standard of Identity for Olive Oil and Olive-Pomace Oil

 

  • After public hearings and the first of two Congressionally mandated reports from FDA, discussed here, the market for FDA-regulated food and dietary supplement products that contain cannabidiol (CBD) continues


Continue Reading FDA Describes “Substantial Progress” Without Providing Any Specific Details on Planned Regulatory Policy for Products Containing CBD

  • On May 26, 2020, the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) issued joint warning letters to four companies for the marketing and sale of products


Continue Reading FDA and FTC Issue Warning Letters to Companies Marketing and Selling Products Deemed Fraudulent for the Treatment or Prevention of COVID-19